Inventiva (IVA) Competitors $5.77 +0.24 (+4.34%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$5.57 -0.20 (-3.47%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IVA vs. IRON, BEAM, CNTA, BLTE, AGIO, HRMY, ANIP, ARQT, DYN, and RXRXShould you be buying Inventiva stock or one of its competitors? The main competitors of Inventiva include Disc Medicine (IRON), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Belite Bio (BLTE), Agios Pharmaceuticals (AGIO), Harmony Biosciences (HRMY), ANI Pharmaceuticals (ANIP), Arcutis Biotherapeutics (ARQT), Dyne Therapeutics (DYN), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry. Inventiva vs. Its Competitors Disc Medicine Beam Therapeutics Centessa Pharmaceuticals Belite Bio Agios Pharmaceuticals Harmony Biosciences ANI Pharmaceuticals Arcutis Biotherapeutics Dyne Therapeutics Recursion Pharmaceuticals Disc Medicine (NASDAQ:IRON) and Inventiva (NASDAQ:IVA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment. Do institutionals & insiders believe in IRON or IVA? 83.7% of Disc Medicine shares are held by institutional investors. Comparatively, 19.1% of Inventiva shares are held by institutional investors. 3.6% of Disc Medicine shares are held by company insiders. Comparatively, 32.0% of Inventiva shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend IRON or IVA? Disc Medicine currently has a consensus target price of $98.30, indicating a potential upside of 63.05%. Inventiva has a consensus target price of $14.83, indicating a potential upside of 157.08%. Given Inventiva's higher probable upside, analysts plainly believe Inventiva is more favorable than Disc Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Inventiva 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has stronger valuation & earnings, IRON or IVA? Disc Medicine has higher earnings, but lower revenue than Inventiva. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$109.36M-$4.47-13.49Inventiva$9.95M55.47-$199.34MN/AN/A Is IRON or IVA more profitable? Inventiva's return on equity of 0.00% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -26.60% -24.58% Inventiva N/A N/A N/A Which has more volatility and risk, IRON or IVA? Disc Medicine has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Inventiva has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Does the media favor IRON or IVA? In the previous week, Disc Medicine had 3 more articles in the media than Inventiva. MarketBeat recorded 11 mentions for Disc Medicine and 8 mentions for Inventiva. Disc Medicine's average media sentiment score of 1.71 beat Inventiva's score of 1.07 indicating that Disc Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Disc Medicine 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Inventiva 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDisc Medicine beats Inventiva on 8 of the 13 factors compared between the two stocks. Get Inventiva News Delivered to You Automatically Sign up to receive the latest news and ratings for IVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IVA vs. The Competition Export to ExcelMetricInventivaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$529.01M$3.15B$5.78B$10.07BDividend YieldN/A2.32%5.69%4.62%P/E RatioN/A21.6074.9726.20Price / Sales55.47297.80472.3091.87Price / CashN/A45.3337.0859.91Price / Book-4.779.7112.116.28Net Income-$199.34M-$53.33M$3.29B$270.85M7 Day Performance3.59%1.04%1.55%3.58%1 Month Performance57.22%9.93%7.83%6.67%1 Year Performance156.44%13.80%61.70%27.73% Inventiva Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IVAInventiva3.0599 of 5 stars$5.77+4.3%$14.83+157.1%+157.6%$529.01M$9.95M0.00100Short Interest ↑Gap DownIRONDisc Medicine3.2931 of 5 stars$61.91+1.9%$98.30+58.8%+24.3%$2.11BN/A-13.8530Positive NewsHigh Trading VolumeBEAMBeam Therapeutics3.0504 of 5 stars$19.94-4.5%$48.45+143.0%-10.7%$2.11B$63.52M-4.43510CNTACentessa Pharmaceuticals3.2465 of 5 stars$18.03+14.6%$31.45+74.5%+64.9%$2.11B$6.85M-10.07200Insider TradeHigh Trading VolumeBLTEBelite Bio2.6717 of 5 stars$67.51+2.7%$96.67+43.2%+40.8%$2.09BN/A-43.5510Positive NewsAGIOAgios Pharmaceuticals4.3547 of 5 stars$36.41+1.1%$56.00+53.8%-17.6%$2.09B$40.88M3.31390Insider TradeHRMYHarmony Biosciences4.5778 of 5 stars$35.83-0.4%$51.00+42.3%-10.4%$2.07B$714.73M11.56200Positive NewsHigh Trading VolumeANIPANI Pharmaceuticals4.0661 of 5 stars$95.20-0.2%$88.25-7.3%+81.8%$2.07B$747.40M-123.63600Positive NewsARQTArcutis Biotherapeutics2.1074 of 5 stars$17.33+1.0%$19.80+14.3%+68.2%$2.06B$196.54M-23.11150Insider TradeDYNDyne Therapeutics3.8139 of 5 stars$13.30-6.5%$34.07+156.1%-59.6%$2.02BN/A-3.45100Positive NewsRXRXRecursion Pharmaceuticals2.4525 of 5 stars$4.62+0.2%$7.25+56.9%-24.8%$2.00B$58.84M-2.60400News CoverageAnalyst ForecastOptions Volume Related Companies and Tools Related Companies IRON Competitors BEAM Competitors CNTA Competitors BLTE Competitors AGIO Competitors HRMY Competitors ANIP Competitors ARQT Competitors DYN Competitors RXRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IVA) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inventiva S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Inventiva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IVA Stock Alerts